$MTEK Cashflow Statement | Understand Stock

$MTEK

$0.40 -$0.01 (1.95%) Close

$MTEK Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net loss from operations
Adjustments required to reconcile net loss to net cash used in operating activities:
Depreciation
Change in fair value of warrants
Share-based compensation
Financial expenses (income)

Increase in accrued severance pay
Decrease (increase) in trade receivables, net
Financial expense (income)
Remeasurement of convertible promissory notes
Increase in short-term bank credit
Decrease (increase) in trade receivables, net
Decrease (increase) in other current assets and prepaid expenses
Increase in inventories
Increase in Severance pay fund
Increase (decrease) in trade payables
Increase (decrease) in other current liabilities
Increase in current liabilities from related parties
Decrease in current liabilities from related parties
Increase (decrease) in accrued severance pay
Net cash used in operating activities
Cash flows from investing activities:
Investment in short-term bank deposits
Proceeds from short-term bank deposits
Investment in marketable equity securities
Proceeds from marketable equity securities
Purchase of property and equipment
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Repayment of short-term bank credit
loan received from shareholders
loan received from related party
Issuance of convertible promissory notes
Increase in short-term bank credit, net
Repurchase of treasury shares
Issuance of shares and warrants
Long-term bank loans paid
Long-term bank loans received
Early repayment of long-term bank loans
Exercise of options and warrants
Repayment of loan from shareholders
Deferred issuance costs

Net cash provided by (used in) financing activities
Increase in cash, cash equivalents and restricted deposits
Cash, cash equivalents and restricted deposits at the beginning of the year
Cash, cash equivalents and restricted deposits at the end of the year
Supplementary disclosure on cash flows:
Interest paid
Interest received
Non-cash deferred issuance costs
Reclassification of warrants to purchase ordinary shares from liability to equity

Supplemental disclosures of non-cash flow information:
Reclassification of warrants to purchase Ordinary Shares from liability to equity
Right-of-use assets obtained in the exchange for operating lease liabilities

Comments